Your session is about to expire
← Back to Search
IN FOCUS for Cancer
Study Summary
This trial will test a new, virtual, group mind-body resiliency intervention to see if it can help cancer survivors who are afraid of their cancer coming back.
- Cancer
- Coping Skills
- Coping Behavior
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the desired outcomes from this research endeavor?
"The overarching purpose of this research, which will be monitored over the timeframe of Baseline to two months, is to measure Acceptability via a 5-point scale. Secondary objectives include evaluating Mind-Body Practice by means of a 17-item questionnaire; Fear of Recurrence with 9 items on the Fear of Cancer Recurrence Inventory severity subscale as well as open questions in an exit interview; and finally, Cancer Related Uncertainty using the 22-item Mishel Uncertainty in Illness Scale - Survivor Version."
Are there any health care facilities undertaking this research project within city limits?
"Five clinical trial sites offer this medication, including Mass General at Emerson Hospital -- Bethke in Concord; Massachusett General Hospital Cancer Center in Boston; and the Mass General/North Shore Cancer Centre of Danvers."
Can patients still register for this research experiment?
"According to clinicaltrials.gov, the recruitment period for this study has ended - it was first uploaded on July 9th 2021 and last edited on July 25th 2022. However, there are still 1,538 other medical trials that are currently enrolling patients across the world."
Share this study with friends
Copy Link
Messenger